Riverside acquires Israeli biomedical device maker

The lower middle market private equity firm has made its first Israel acquisition as an add-on for Hungarian portfolio company Diatron.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this